Pancreatic Cancer Research

ResearcherUniversity of MinnesotaActive in the last 2 years

Alexander K. Tsai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4014-1946; OpenAlex author ID A5047374406. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2025: 2 papers · 2026: 2 papers

Papers 4

  1. Treg cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I-deficient metastatic pancreatic cancer. Co-author DOI 10.1126/sciimmunol.adz4302↗
  2. Promoting tumor antigen presentation unleashes therapeutic efficacy of Tgfbr2-deficient TCR-engineered T cells in pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/jitc-2026-015489↗
  3. IL-15 complex enhances therapeutic efficacy of anti-PD-L1 in a T cell-dependent and NK cell-independent manner in a murine model of pancreatic ductal adenocarc… First author DOI 10.1093/jimmun/vkaf314↗
  4. IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/2326-6066.cir-24-0758↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ingunn M. Stromnes · 4 shared papers, 2025–2026 · strength 0.92
  2. Adam L. Burrack · 4 shared papers, 2025–2026 · strength 0.92
  3. Zoe C. Schmiechen · 4 shared papers, 2025–2026 · strength 0.92
  4. Grant H. Hickok · 3 shared papers, 2025–2026 · strength 0.64
  5. Cara-lin Lonetree · 2 shared papers, 2025–2026 · strength 0.41
  6. David Masopust · 1 shared paper, 2026 · strength 0.23
  7. Paolo Provenzano · 1 shared paper, 2026 · strength 0.23
  8. Guhan Qian · 1 shared paper, 2026 · strength 0.23
  9. Philip D. Greenberg · 1 shared paper, 2026 · strength 0.23
  10. Sunil R. Hingorani · 1 shared paper, 2026 · strength 0.23
  11. Liang‐I Kang · 1 shared paper, 2026 · strength 0.22
  12. David G DeNardo · 1 shared paper, 2026 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.